PRONOTA
DEAD

Serial Number

77029232

Owner

Pronota NV

Attorney

Mark Harrison

Filing Date

Oct 25, 2006

Add to watchlist:

No watchlists yet
View on USPTO

PRONOTA Trademark

Serial Number: 77029232 • Registration: 3878388

PRONOTA is a trademark filed by Pronota NV on October 25, 2006. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Pronota NV (4 trademarks)

Technologiepark 4; VIB Bio-Incubator
Zwijnaarde/Ghent B-9052 , BE

Entity Type: 03

Peakadilly NV

Technologiepark 4
Zwijnaarde/Ghent B-9052 , BE

Entity Type: 03

Trademark Details

Filing Date

October 25, 2006

Registration Date

November 23, 2010

Published for Opposition

September 7, 2010

Cancellation Date

June 30, 2017

Goods & Services

Scientific apparatus for analyzing proteins, blood, cell lysates and bodily fluids, namely, liquid chromatography apparatus and mass spectrometry apparatus for analyzing proteins, blood, cell lysates and bodily fluids; mass spectrometers for analyzing peptides and proteins; fluid separation apparatus for the separation of peptides and proteins for individual analysis; electronic databases recorded on computer media for use in medical diagnostics; computer software for use in the field of medical diagnostics; chromatography apparatus for laboratory use; liquid or gas chromatography apparatus for identifying peptides

Diagnostic preparations for medical use, namely, preparations for the diagnosis of disease, infection or illness, or predisposition to disease, infection or illness, or predisposition to disease, infection or illness; diagnostic preparations and substances for medical use in the medical analysis of proteins, blood and cell lysates and bodily fluids; protein and peptide biomarkers for use in the medical diagnosis of disease, infection or illness and predisposition to disease, infection or illness; diagnostic products and preparations and preparations for medical use comprising one or more biomarkers for the diagnosis of disease, infection or illness, and predisposition to disease, infection or illness; diagnostic products and preparations and preparations for medical use comprising one or more proteins or peptides or aptamers for the diagnosis of disease, infection or illness, and predisposition to disease, infection or illness; medical diagnostic kits comprised of one or more biomarkers and excipients for biomarker and protein analysis; medical diagnostic kits comprised of one or more peptides or aptamers and excipients for biomarker and protein analysis

Medical diagnosis services in the field of medical diagnosis of disease, illness and infection and in the field of identification of indicators of and for disease, illness and infection; medical services; medical diagnostic testing services; medical profiling of humans to predict their response to drugs; medical profiling for disease prognosis, diagnosis and progression, namely, preparing profiles of proteins present in patients for disease prognosis, diagnosis and progression; medical consultation services in the field of comparison and quantification of protein and peptide profiles; provision of medical information; medical analysis for the diagnosis and treatment of persons; provision of medical information arising from analysis for the diagnosis and treatment of persons; medical testing, namely, testing of proteins, blood, cell lysates and bodily fluids; leasing of medical equipment; provision of information from a computer database in the field of medical diagnostics and indicators of and for disease, illness and infection; testing services in the field of medical diagnosis of disease, illness and infection and in the field of identification of indicators of and for disease, illness and infection; analytical testing in the field of medical diagnosis of disease, illness and infection and in the field of identification of indicators of and for disease, illness and infection

Medical apparatus and instruments for obtaining, sampling and analyzing biological matter, blood, cell lysates and bodily fluids; chromatography apparatus for medical use; chromatography apparatus for identifying peptides or aptamers for medical purposes; separation apparatus for isolating proteins from a biological sample for medical purposes

Scientific and technological services and research and design in the field of medical diagnosis of disease, illness and infection and in the field of identification of indicators of and for disease, illness and infection; design and development of computer software and databases in the field of medical diagnosis; chemistry services; laboratory services in the field of medical diagnosis of disease, illness and infection and in the field of identification of indicators of and for disease, illness and infection; medical research services; medical and scientific research in the field of comparison and quantification of proteins and peptide profiles; scientific research services featuring discovery, identification, profiling, development and validation in the field of biomarkers, protein biomarkers and peptide biomarkers; scientific and technological services to identify, develop and validate biomarker assays; scientific and technological services to identify and develop peptides or aptamers as biomarkers for protease activity; scientific and technological services to identify and develop peptides including aptamers as biomarkers for inhibition of protease activity; laboratory analysis of proteins, blood and other biological matter

Filing History

CANCELLED SEC. 8 (6-YR)
Jun 30, 2017 C8..
REGISTERED-PRINCIPAL REGISTER
Nov 23, 2010 R.PR
PUBLISHED FOR OPPOSITION
Sep 7, 2010 PUBO
NOTICE OF PUBLICATION
Aug 18, 2010 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 5, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2010 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 3, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 3, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 3, 2010 TROA
NON-FINAL ACTION MAILED
Feb 3, 2010 CNRT
NON-FINAL ACTION WRITTEN
Feb 3, 2010 CNRT
ASSIGNED TO EXAMINER
Jan 5, 2010 DOCK
ASSIGNED TO EXAMINER
Jan 5, 2010 DOCK
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 4, 2010 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 28, 2009 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 11, 2009 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 8, 2009 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 24, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 24, 2009 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 20, 2009 ERFR
FINAL REFUSAL MAILED
Jun 9, 2009 CNFR
FINAL REFUSAL WRITTEN
Jun 8, 2009 CNFR
AMENDMENT FROM APPLICANT ENTERED
May 15, 2009 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 15, 2009 CRFA
PAPER RECEIVED
May 12, 2009 MAIL
NON-FINAL ACTION MAILED
Nov 13, 2008 CNRT
NON-FINAL ACTION WRITTEN
Nov 12, 2008 CNRT
AMENDMENT FROM APPLICANT ENTERED
Oct 22, 2008 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 22, 2008 CRFA
ASSIGNED TO LIE
Oct 20, 2008 ALIE
PAPER RECEIVED
Oct 17, 2008 MAIL
INQUIRY AS TO SUSPENSION MAILED
Apr 18, 2008 CNSI
SUSPENSION INQUIRY WRITTEN
Apr 18, 2008 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Mar 21, 2008 RCCK
LETTER OF SUSPENSION MAILED
Aug 30, 2007 CNSL
SUSPENSION LETTER WRITTEN
Aug 30, 2007 CNSL
AMENDMENT FROM APPLICANT ENTERED
Aug 24, 2007 ACEC
ASSIGNED TO LIE
Aug 20, 2007 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 30, 2007 CRFA
PAPER RECEIVED
Jul 30, 2007 MAIL
NON-FINAL ACTION MAILED
Mar 12, 2007 CNRT
NON-FINAL ACTION WRITTEN
Mar 10, 2007 CNRT
ASSIGNED TO EXAMINER
Mar 7, 2007 DOCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 24, 2007 ASGN
NEW APPLICATION ENTERED
Oct 30, 2006 NWAP